Upcoming Stock Splits This Week (May 11 to May 15) – Stay Invested

These are the upcoming stock splits for the week of May 11 to May 15, based on TipRanks’ Stock Splits Calendar. A stock split is basically a company’s way of making its stock feel more approachable for everyday investors. The number of shares increases while the price of each share comes down, making the stock look cheaper and easier to buy. In many cases, that can help boost trading activity and liquidity.

These days, however, many – if not most – stock splits are actually reverse splits. In a reverse stock split, a company reduces the number of shares outstanding by combining existing shares into fewer, higher-priced ones. These moves are often tied to compliance concerns, particularly the need to satisfy minimum share price requirements on exchanges such as Nasdaq and avoid the risk of delisting.

Whether aimed at accessibility or compliance, stock splits and reverse splits tend to attract investor interest. Beyond the mechanical changes, they can offer insight into how management views the company’s current position, shareholder base, and path forward.

Let’s take a look at the upcoming stock splits for the week.

Xiao-I Corporation (AIXI) – Xiao-I is a China-based cognitive AI company focused on conversational AI, enterprise digital transformation, and intelligent customer-service platforms. The company provides AI-powered solutions for industries including finance, healthcare, transportation, and telecommunications, while also developing large language model technologies and virtual human applications. Yet, the stock has tumbled sharply over the past year amid investor skepticism surrounding the company’s long-running patent litigation against Apple. On May 7, Xiao-I announced a 1-for-20 reverse split of its American Depositary Shares through an ADS ratio change designed to help maintain compliance with Nasdaq listing requirements. The split is set to take effect on May 11.

KALA BIO (KALA) – KALA BIO is a clinical-stage biotechnology company focused on developing therapies for rare and severe eye diseases. The company has concentrated on regenerative medicine and specialty ophthalmology, targeting conditions affecting the cornea and ocular surface. KALA previously commercialized EYSUVIS and INVELTYS before shifting toward earlier-stage ophthalmic programs. Shares have tumbled after KPI-012 failed a mid-stage clinical trial, prompting the company to discontinue development of the program and raise concerns about its financial position and pipeline outlook. On May 7, KALA announced a 1-for-50 reverse stock split as part of its effort to regain compliance with Nasdaq’s minimum bid price requirement. The split will take effect on May 11.

SMX Public Limited Company (SMX) – SMX is an Ireland-based technology company specializing in molecular marking and blockchain-based tracking systems designed to authenticate and trace products across global supply chains. The company’s platform allows materials and products to carry invisible molecular markers that can verify origin, recycling history, and authenticity in industries ranging from metals and plastics to luxury goods and agriculture. However, SMX hares have crashed as investors grew concerned about the company’s limited commercial revenue, questioned the broader adoption of its technology, and reacted to continued dilution tied to financing activities. On May 2, the company’s shareholders approved a proposal allowing the board to consolidate or divide the company’s share classes, paving the way for a reverse stock split. Then, on May 7, SMX confirmed that its 1-for-20 reverse stock split of ordinary shares will take effect on May 11.

Aspire Biopharma (ASBP) – Aspire Biopharma is a biotechnology company developing a patent-pending drug delivery platform designed to improve how medications are absorbed and administered. The company is working on formulations intended to provide faster onset, improved bioavailability, and more convenient delivery across multiple therapeutic categories. Aspire shares crashed in mid-April after the company signed a Letter of Intent to acquire Dura Driver Control Systems, an automotive supplier, for $30 million. While intended to boost revenue and equity to meet Nasdaq requirements, the market reacted with skepticism to such a drastic pivot away from its core sublingual drug delivery technology. On May 7, the company announced a 1-for-30 reverse stock split to meet Nasdaq’s minimum bid price requirement. The split is set to take effect on May 11.

DarkIris (DKI) – DarkIris is a Hong Kong-based entertainment technology company that originally focused on developing and publishing mobile games but has recently shifted toward AI-generated content, film production, and broader AI-driven entertainment initiatives. The company is pursuing an ambitious strategy centered on Artificial Intelligence Generated Content (AIGC), including AI tools for gaming, video, and film creation, while also acquiring entertainment IP assets and expanding into AI infrastructure services. Investors, however, have grown concerned over the company’s heavy losses, repeated dilution, speculative AI pivot, and Nasdaq compliance struggles, all of which contributed to a sharp collapse in the stock price. On May 7, the company announced a 1-for-16 reverse stock split of its Class A ordinary shares to address Nasdaq’s minimum bid price requirement. The split is expected to take effect on May 11.

Solmate Infrastructure (SLMT) – Solmate Infrastructure is a crypto infrastructure company building institutional-grade Solana staking, validator, and treasury infrastructure. The company is focused on expanding blockchain infrastructure and low-latency validator operations tied to the Solana ecosystem. Solmate emerged from Brera Holdings’ sports-focused business model and has been redirecting capital away from legacy football operations toward digital asset infrastructure and treasury initiatives. On May 5, the company confirmed that its previously approved 1-for-10 reverse share split is expected to take effect on or about May 14 as part of its effort to regain compliance with Nasdaq’s minimum bid price requirement.

Muncy Columbia Financial (CCFN) – Muncy Columbia Financial is the bank holding company for Journey Bank, a Pennsylvania-based community bank serving consumers, businesses, and municipal clients across the region. The company provides traditional banking services including commercial lending, residential mortgages, wealth management, and trust services, while maintaining a strong presence in local community banking markets. Stable profitability and conservative balance-sheet management have helped distinguish the company from many smaller regional peers. On April 23, the company announced a 3-for-1 stock split in the form of a 200% stock dividend aimed at improving liquidity and making shares more accessible to investors. The additional shares are scheduled to be distributed after the close of business on May 14.

To find more information about historical and upcoming stock splits, visit the TipRanks Stock Splits Calendar.